AZ loses round in Lucentis patent fight

An English judge has dealt a blow to AstraZeneca by overruling the patent rights of MedImmune, its subsidiary, to a screening technique used in drugs like Roche's blockbuster eye treatment Lucentis. The two companies are also litigating over the patent rights in other countries including France, Germany, the Netherlands and Switzerland. Report